Objective: To examine psychiatric and somatic correlates of DSM-5 eating disorders (EDs)-anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED)-in a nationally representative sample of adults in the United States.
New studies of prevalence and correlates of EDs are needed in light of these changes in the DSM-5. A few epidemiological studies have attempted to estimate the impact of changes between DSM-IV and DSM-5 on the prevalence of AN, BN, and BED (Cossrow et al., 2016; Hudson, Coit, Lalonde, & Pope Jr., 2012; Mohler-Kuo, Schnyder, Dermota, Wei, & Milos, 2016; Trace et al., 2012) . Those studies suggested that DSM-5-based criteria for these three specific EDs would yield higher prevalence estimates. Udo and Grilo (2018) , in the first study of lifetime and 12-month prevalence estimates of EDs in a large nationally representative study with US adults, reported similar (slightly higher) estimates for AN but lower estimates for BN and BED. To understand a full scope of clinical and public health implications of changes in diagnostic criteria for EDs, it is also important to evaluate their psychiatric comorbidities and somatic correlates DSM-5 definitions. Previous research has generally reported that EDs are frequently associated with elevated rates of other psychiatric disorders, including mood disorders, anxiety disorders, substance use disorders, impulse control disorders, and personality disorders, across clinical, community, and epidemiological samples (Grilo, White, Barnes, & Masheb, 2013; Hudson, Hiripi, Pope Jr., & Kessler, 2007; Ulfvebrand, Birgegård, Norring, Högdahl, & von Hausswolff-Juhlin, 2015; Welch et al., 2016) . Recognizing and understanding associated psychiatric comorbidities is important for treatment planning and informing research (Newman, Moffitt, Caspi, & Silva, 1998) .
Similarly, understanding associations with medical or health problems can inform improved screening, recognition, and medical management. Across clinical and larger community or epidemiological studies, EDs have shown significant, albeit highly variable, associations with various medical problems (Javaras et al., 2008; Kessler et al., 2013) . Clinically, some of these associations appear to partly reflect the symptomatic features (e.g., high purging or laxative misuse associated with gastrointestinal issues) (Brown & Mehler, 2015; Mehler & Rylander, 2015; Sato & Fukudo, 2015) or associated features (e.g., excess weight and obesity associated with BED also being associated with metabolic disturbances) (Kessler et al., 2013) . One recent study, based on the Swedish population registry, reported that DSM-5 BED was associated with respiratory diseases, endocrine system diseases, musculoskeletal system and connective tissues diseases, and skin diseases (Thornton et al., 2017) .
Thus, a little is known about psychiatric and somatic correlates of DSM-5 EDs in the general population. The third wave of the national epidemiologic survey on alcohol and related conditions (NESARC-III) is the largest epidemiologic household survey of US adults that has assessed EDs along with psychiatric and somatic correlates (Grant et al., 2014) . Thus, this study aimed to examine psychiatric and somatic correlates of DSM-5 EDs in a nationally-representative sample of US adults using data from the NESARC-III.
2 | METHOD 2.1 | Study sample NESARC-III, designed originally to estimate the prevalence of alcohol use and related conditions in adults, included 36,309 noninstitutionalized US civilians 18 years and older (Grant et al., 2014; Grant et al., 2016 ). The sample is composed of 56.3% women and, in terms of ethnicity/race, 52.9% non-Hispanic White, 21.4% non-Hispanic Black, 19.4% Hispanic, and 6.4% "Other" groups; 22.4% of the respondents were ages between 18 and 29, 27.9% were between ages 30 and 44, 26.7% were ages between 45 and 59, and 23.0% were above 60 years old (mean age = 45.6 AE 17.5 years; see for the weighted sample sociodemographic characteristics). Multistage probability sampling was employed with counties or groups of contiguous counties as primary sampling units, groups of Censusdefined blocks as secondary sampling units, and households within secondary sampling units as tertiary sampling units. Eligible adults were randomly selected from each household, but Hispanic, Black, and Asian household members were oversampled (i.e., two respondents from households with more than four eligible minority members). NESARC had an overall response rate of 60.1% (72% household response rate and 84% person-level response rate; see Grant et al., 2016 for details). Between April 2012 and June 2013, participants completed computer-assisted face-to-face personal interviews performed by 970 trained lay-assessors who had, on average, 5 years of experience performing health-related surveys. NERSAC-III received an approval from the National Institute of Health (NIH) Institutional Review Board (IRB) and participants provided oral informed consent ; IRB-exempt approval was obtained from University at Albany to perform the present analyses.
| Measures

| Diagnostic assessment of EDs and other psychiatric disorders
A structured diagnostic interview, the NIAAA alcohol use disorder and associated disabilities interview schedule-5 (AUDADIS-5; Grant et al., 2011) , was used to assess a range of DSM-5-defined psychiatric disorders and their criteria, including specific information for AN, BN, and BED diagnoses.
AUDADIS-5-generated lifetime psychiatric disorders as coded by NESARC-III were used in this study. This included mood disorders (major depressive episodes, persistent depression, and bipolar I), anxiety disorders (specific phobia, social phobia, panic disorders, agoraphobia, and generalized anxiety disorder), posttraumatic stress disorder (PTSD), substance use disorders (SUD), alcohol use disorder (AUD), drug use disorder, nicotine use disorder, personality disorders (antisocial, borderline, and schizotypal), and conduct disorder. To investigate the validity of the AUDADIS-5, it was compared with the Psychiatric Research Interview for Substance and Mental Disorders, DSM-5 version (PRISM-5) administered by clinicians blinded to AUDADIS-5 findings; concordance was fair-to-moderate for diagnostics (k = 0.24-0.72) and fair-to-excellent for dimensional measures of SUD, mood disorders, anxiety disorders, and PTSD (ICC = 0.43-0.72; . Test-retest reliability of the AUDADIS-5 for diagnosing specific disorders (non-ED categories) ranged from fair-to-excellent (k = 0.35-0.87) for diagnosis of SUD, mood disorders, anxiety disorders, PTSD, and personality disorders, and from good- Unfortunately, the NESARC studies on validity and reliability of the AUDADIS-5 did not include EDs. As we detailed in our previous paper on the prevalence of EDs in NESARC-III (Udo & Grilo, 2018 
| Sociodemographic covariates
Respondents provided information about their sociodemographic status, including age, sex, ethnicity/race (non-Hispanic White, nonHispanic Black, Hispanic, non-Hispanic Asian/Pacific Islander, and American Indianan/Alaska Native), and education (categorized as less than H.S., H.S. or GED, at least some college).
| Statistical analysis
Analyses were conducted with the Statistical Analysis System (SAS) (release 9.4, 2002-2012) , and accounted for NESARC-survey design by using Proc Survey procedures with Taylor series variance estimation method. For each ED, weighted means, frequencies and cross-tabulations were computed for prevalence of comorbid psychiatric and somatic conditions. Individuals without a lifetime history of AN, BN, or BED diagnosis served as the comparison group (no-specific ED). For these inferential statistics comparing these three specific ED groups and no-specific ED group, we followed the well-established diagnostic "hierarchy" of AN>BN > BED [all lifetime diagnoses]) was used to be consistent with prior studies on the epidemiology of various psychiatric disorders based on this data set Grant et al., 2016; Hasin et al., 2016; Hasin et al., 2018) , and to investigate the statistically independent associations between three specific EDs and their psychiatric and somatic correlates (Model 2).
| RESULTS
Lifetime prevalence of AN, BN, and BED was 0.80% (0.07%), 0.28% (0.03%), and 0.85% (0.05%), respectively (see Udo & Grilo, 2018 , for more information on the prevalence estimates, including by sex and by ethnicity/race). Table 1 summarizes lifetime prevalence estimates (%) and standard errors of each psychiatric disorder across lifetime AN, BN, BED, and the no-specific ED groups. 87.3% of respondents with AN, 94.4% with BN, and 93.8% with BED met criteria for at least one additional NESARC-III-assessed DSM-5 lifetime psychiatric disorder. The lifetime prevalence rates for all psychiatric disorders were substantially higher in the ED groups than the no-specific ED group. Overall, all three ED groups had a significantly greater number of comorbid lifetime psychiatric conditions than the no-specific ED group; the lifetime BED group met criteria for significantly greater number of lifetime psychiatric diagnoses than the lifetime AN group (2.3 vs 1.7; t[113] = −3.19, p = .001) after adjusting for sociodemographic variables.
| Lifetime psychiatric comorbidity
As shown in Table 2 , after adjusting for sociodemographic variables, the three EDs were significantly associated with all other lifetime psychiatric disorders (except for BN with specific phobia).
When additionally adjusting for other lifetime psychiatric disorders (Model 2), AN was significantly associated with any mood disorders, major depressive disorder, persistent depression, panic disorder, agoraphobia, PTSD, any SUDs, AUD, any personality/conduct disorder, borderline personality disorder, and conduct disorder. BN was significantly associated with any mood disorders, major depressive disorder, persistent depression, AUD, borderline personality disorder, and conduct disorder. BED was significantly associated with any mood disorders, major depressive disorder, persistent depression, any anxiety disorders, all individual anxiety disorders (except for panic disorder), PTSD, AUD, any personality or conduct disorders, and all individual personality and conduct disorders. Table 3 summarizes prevalence estimates (%) and standard errors of each chronic somatic condition across each specific ED and no-specific ED groups. Across all three specific EDs, over half of respondents reported having been diagnosed with at least one somatic condition in the past 12 months (59.7 AE 3.51% for AN, 54.5 AE 5.06% for BN, and 68.6 AE 3.03% for BED). The total number of diagnosed chronic somatic conditions in the past 12 months was significantly greater for AN and BED than the no-specific ED group.
| Chronic somatic conditions
As shown in Table 4 , after adjusting for sociodemographic variables, AN was associated with significantly greater odds of reporting minor heart conditions, stomach ulcer, sleep problems, cancer, anemia, fibromyalgia, osteoporosis, and nerve problems. When additionally adjusting for other psychiatric conditions, odds ratios for fibromyalgia, cancer, anemia, and osteoporosis remained significant in AN. When adjusting only for sociodemographic variables, BN was significantly associated with increased odds of arteriosclerosis, minor heart conditions, stomach ulcer, epilepsy or seizure, and sleep problems. All associations became nonsignificant after additionally adjusting for other psychiatric disorders, however, odds of fibromyalgia, became significantly less for BN. After adjusting for sociodemographic variables, BED was significantly associated with increased odds of diabetes, hypertension, high cholesterol, high triglycerides, minor heart conditions, stomach ulcer, arthritis, sleep problems, anemia, fibromyalgia, bowel problems, osteoporosis, lung problems, liver diseases, and nerve problems. Finally, after additionally adjusting for other psychiatric disorders, odds ratios for diabetes, hypertension, high cholesterol, and high triglycerides remained significant.
| DISCUSSION
This study reports psychiatric comorbidities and somatic conditions associated with DSM-5-defined EDs in a nationally-representative sample of adults in the US. Overall, we found that DSM-5 EDs were significantly and highly associated with other psychiatric disorders.
While only 57.6% of individuals with no history of EDs met criteria for at least one lifetime psychiatric diagnosis, among the ED diagnoses, 87.3% of AN, 94.4% of BN, and 93.8% BED met criteria for an additional psychiatric disorder. Overall, these findings are generally consistent with previous, a smaller nationally-representative US study (Hudson et al., 2007) .
Overall the most frequently occurring comorbid diagnoses with three specific EDs were mood disorders and substance use disorders (both occurring in roughly half to two-thirds of cases), followed by anxiety disorders (occurring in nearly half of cases). For all specific EDs, odds of lifetime diagnosis were significantly increased for major depressive disorder, persistent depression, AUD, borderline personality disorder, and conduct disorder, even after adjusting for other psychiatric disorders. BED had the greatest number of significant associations with other psychiatric disorders and BN had the least.
We note some divergences in our observed psychiatric comorbidity patterns from those reported previously with DSM-IV (Hudson et al., 2007) . We found a higher rate of psychiatric comorbidity for DSM-5-defined AN and BN than the previous NCS-R study (Hudson et al., 2007) and our rate of substance use disorders across all EDs Notes. AOR = adjusted odds ratio. CI = 95% confidence interval. Model 1 = adjusting for age, sex, race/ethnicity, and education. Model 2 = adjusting for sociodemographic variables and other psychiatric conditions (any mood disorders, any anxiety disorders, any substance use disorders, any personality/conduct disorders, and PTSD). All analyses adjusted for complex survey design of NESARC-III. *Significant at p < .01.;
**Significant at p < .05.
Significant results are highlighted by bold letters.
was greater. Differences in patterns of associations with previous epidemiological estimates (Hudson et al., 2007; Ulfvebrand et al., 2015) may be the result of changes in the DSM-5 diagnostic criteria not only for EDs but also for other psychiatric disorders (e.g., removal of abuse vs. dependence distinction in substance use disorders; Bartoli, Carrà, Crocamo, & Clerici, 2015; Hasin et al., 2013) . Particularly for SUD, changes in the strength of associations may be attributable partly to general increases in its prevalence (e.g., Grant et al., 2017; Hasin et al., 2016 [Grant et al., 2011] ).
DSM-5
EDs were also associated with high rates of chronic somatic conditions. Lifetime diagnoses of AN and BED were associated with significantly greater number of chronic somatic conditions than those without lifetime diagnosis of three specific EDs. After adjusting for sociodemographic characteristics, AN was associated with significantly increased odds of minor heart conditions, stomach ulcer, sleep problems, anemia, cancer, fibromyalgia, osteoporosis, and nerve problems.
Even when additionally adjusting for other psychiatric disorders, only fibromyalgia, cancer, anemia, and osteoporosis remained significantly associated with AN. We emphasize that the cross-sectional nature of the data analyses precludes any firm interpretations. We cautiously note that some of these findings might fit clinical reports. For example, our finding regarding osteoporosis in AN is well-documented (Robinson, Aldridge, Clark, Misra, & Micali, 2016) . The findings of a possible association between cancer and AN has been reported inconsistently in the literature with most studies focusing specifically on breast cancer (Mellemkjaer et al., 2001; Michels & Ekbom, 2004; O'Brien, Whelan, Sandler, & Weinberg, 2017) . A study pooled population medical registry data from Finland, Denmark, and Sweden suggested significantly increased incidence rate ratios, particularly for esophageal, lung, and liver cancer (Mellemkjaer et al., 2015) .
BED was associated with significantly increased odds of many somatic conditions including minor heart conditions, stomach ulcer, diabetes, hypertension, dyslipidemias, sleep problems, pain conditions, and gastrointestinal symptoms are commonly comorbid somatic conditions in BED. In addition, Olguin et al. (2016) suggested that more studies are needed to determine whether the associations between BED and these somatic conditions are above and beyond the effects of obesity or other psychiatric comorbidity. Importantly, our current analyses suggest that many somatic comorbidities in BED exist after adjusting for other psychiatric conditions. Moreover, as we emphasize below, the causal nature of these associations is unclear.
Strengths of the current study include the use of a large epidemiological data set with a representative sample of 36,309 US adults and broad coverage of comorbid psychiatric and chronic somatic conditions. Our large sample provided greater precision (i.e., leading to smaller confidence intervals and greater ability to detect smaller effects) than previous studies and allowed reasonably for adjusting for other psychiatric disorders in addition to sociodemographic factors.
The study also has potential limitations. The AUDADIS-5 structured instrument was administered by lay, albeit experienced, interviewers, not by clinicians; standardized training, however, may offset this limitation to some degree. The AUDADIS-5 has not been evaluated for reliability and validity of ED diagnosis, although it has been validated for other psychiatric conditions (Grant, Goldstein, Saha, et al., 2015; ; it is therefore important that the AUDADIS-5 will be validated for DSM-5 ED diagnoses. The skip-out rules and the lack of specific details in the questions within ED sections in the AUDADIS-5 might have resulted in possible underestimation of the prevalence rates due to missing data, and precluded us from investigating subthreshold BN and BED, as well as other specified feeding or eating disorder (OSFSD) (Supporting Information Tables S1 and S2 ).
Collectively, these limitations highlight the complexity of assessment issue in epidemiological research that are not limited to the AUDADIS-5, and represent an important challenge for the field and provide critical context for interpreting results (Udo & Grilo, in press ).
The NESARC-III relied on self-report for diagnoses of chronic somatic conditions rather than medical records; this may introduce some degree of bias although it is a standard approach in large-scale studies. Research should examine validity and accuracy of such selfreported diagnoses of somatic conditions. Importantly, the causal nature of the observed associations is unclear. Future research should examine temporal aspects or sequencing for the ED and psychiatric conditions even though such analyses would be limited in how they might speak to causality (e.g., they might provide clues for hypotheses about potential direct effects but not about other common causes of both disorders). Due to limited sample sizes for men and racial minorities with positive AN, BN, or BED diagnosis, the study was unable to investigate sex and racial/ethnic differences in the relationships between three specific EDs, other psychiatric disorders, and chronic somatic conditions, and thus further epidemiological research to investigate this question is warranted. Although the NESARC-III is a carefully designed study and allows adjustment of population rates and other complex survey designs in calculation of prevalence, the sample may not be perfectly representative of the US adult population for the limitations commonly reported in many census studies (e.g., focus on noninstitutionalized individuals, possible differences between those who are and are not willing to complete a lengthy survey).
In conclusion, our findings for DSM-5-defined AN, BN, and BED, based on a large national sample of US adults, indicate that these disorders are associated with significantly elevated rates of other major psychiatric disorders and somatic conditions. The elevated rates of comorbidities were observed even after adjusting for sociodemographic characteristics and other psychiatric disorders. EDs are prevalent across different sociodemographic groups, and are associated with serious impairment in psychosocial functioning (Udo & Grilo, 2018) . Our findings underscore the importance of screening of additional psychiatric and somatic conditions in those identified with EDs to reduce the disease burdens due to medical comorbidities.
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